# US 2023/0263999 A1 · Systems and methods of restoring perfusion to a vessel

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0263999 A1
- Document ID: US20230263999A1
- Status: Published application
- Kind: A1
- Application number: 18/104,611
- Filed: 2023-02-01
- Published: 2023-08-24
- Earliest claimed: 2022-02-23
- Assignees: Neuravi Limited
- Applicants: Neuravi Limited
- Inventors: David VALE; Brendan CASEY; Michael GILVARRY; Jacqueline O'GORMAN; Daniel KING; Kevin McARDLE; Brian FAHY; Mairsil CLAFFEY; Malgorzata Alicja KOKOSZKA
- Web page: https://patentgrep.com/patent/US20230263999A1

## CPC

- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61B 17/12109: {in a blood vessel}
- A61M 25/0662: {Guide tubes}
- A61B 17/221: Gripping devices in the form of loops or baskets {for gripping calculi or similar types of obstructions (surgical snare instruments A61B17/32056)}
- A61B 2017/2215: {having an open distal end}
- A61B 2090/3966: {Radiopaque markers visible in an X-ray image}
- A61F 2/90: characterised by a net-like or mesh-like structure
- A61M 2025/0042: {Microcatheters, cannula or the like having outside diameters around 1 mm or less}
- A61M 2025/0681: {Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A method and/or use of restoring blood flow in neurovasculature by removing thrombus in a plurality of human patients experiencing ischemic stroke. A first stent retriever device is passed by, through, or about a cerebral occlusion in a blood vessel of one of the plurality of human patients. Then a revascularization device is passed by, through, or about the cerebral occlusion in the blood vessel of the one of the plurality of human patients to restore perfusion to the blood vessel and achieve at least approximately 88% final revascularization rate for the plurality of human patients under the modified treatment in cerebral infarction score of equal to or greater than a grade of 2b (mTICI≥2b).

## Claims

### Claim 1

A method or use of restoring blood flow in neurovasculature by removing thrombus in a plurality of human patients experiencing ischemic stroke, the method or use comprising:
passing a first stent retriever device by, through, or about a cerebral occlusion in a blood vessel of one of the plurality of human patients; then
passing a revascularization device by, through, or about the cerebral occlusion in the blood vessel of the one of the plurality of human patients to restore perfusion to the blood vessel and achieve at least approximately 88% final revascularization rate for the plurality of human patients under the modified treatment in cerebral infarction score of equal to or greater than a grade of 2b (mTICI≥2b).

### Claim 2 (depends on 1)

The method or use of claim 1, the step of passing the revascularization device comprises retracting the revascularization device, after being passed by, through or about the cerebral occlusion, while pinching the cerebral occlusion.

### Claim 3 (depends on 1)

The method or use of claim 1, the revascularization device being configured to remove the cerebral occlusion or portions thereof that are fibrin-rich.

### Claim 4 (depends on 1)

The method or use of claim 1, wherein the plurality of human patients comprising at least approximately 50 patients.

### Claim 5 (depends on 1)

The method or use of claim 1, wherein the plurality of human patients comprising at least approximately 80 patients.

### Claim 6 (depends on 1)

The method or use of claim 1, further comprising:
confirming angiographically, after the step of passing the first stent retriever device, that the revascularization rate is less than a grade of 2b (mTICI<2b).

### Claim 7 (depends on 6)

The method or use of claim 6, inclusion criteria for the plurality of human patients comprising:
Aged ≥18; and
mRS 0-1 prior to a stroke corresponding to the cerebral occlusion.

### Claim 8 (depends on 1)

The method or use of claim 1, exclusion criteria for the plurality of human patients comprising:
Patients in observational, natural history, and/or epidemiological studies involving intervention;
Confirmation of positive pregnancy test according to site specific standard of care;
Patients who had direct aspiration via syringe/mechanical pump during the first and/or second pass attempt prior to the revascularization device;
All patients with severe hypertension on presentation (SBP>220 mmHg and/or DBP>120 mm Hg). All patients, in whom intravenous therapy with blood pressure medications was indicated, with hypertension that remained severe and sustained despite intravenous antihypertensive therapy (SBP>185 mmHg and/or DBP>110 mmHg);
Known cerebral vasculitis;
Known cancer with life expectancy less than 12 months;
Stenosis, or any occlusion, in a proximal vessel that requires treatment or prevents access to the site of occlusion;
Intracranial stenosis that prevented access to the site of occlusion;
Computed tomography (CT) or Magnetic Resonance Imaging (MRI) evidence of recent/fresh hemorrhage on presentation;
Baseline CT or MRI showing mass effect or intracranial tumor (except small meningioma);
Evidence of dissection in the extra or intracranial cerebral arteries; and
Occlusions in multiple vascular territories (i.e. bilateral anterior circulation, or anterior/posterior circulation).

### Claim 9 (depends on 1)

The method or use of claim 1, the method or use being performed within approximately 6 hours of stroke symptom onset.

### Claim 10 (depends on 1)

The method or use of claim 1, the method or use being performed within approximately 8 hours of stroke symptom onset.

### Claim 11 (depends on 1)

The method or use of claim 1, the method or use being performed within approximately 24 hours of stroke symptom onset.

### Claim 12 (depends on 1)

The method or use of claim 1, the cerebral occlusion being positioned in an internal carotid artery, a M1 segment and/or a M2 segment of a middle cerebral artery, a vertebral artery, or a basilar artery of the patient, the patient being a human.

### Claim 13 (depends on 1)

The method or use of claim 1, the revascularization device having a collapsed delivery configuration and an expanded deployed configuration, the revascularization device comprising a proximal pinch section comprising a spiral shape comprising a spiral pitch; and a distal section comprising a barrel shape.

### Claim 14 (depends on 13)

The method or use of claim 13,
wherein, in the expanded configuration, the revascularization device comprises peaks of the proximal pinch section are laterally spaced-apart and when under tension,
the method or use comprising:
pinching the cerebral occlusion between the peaks.

### Claim 15 (depends on 13)

The method or use of claim 13, the proximal pinch section comprising a plurality of cells defined by struts and crowns connected to corresponding struts and/or crowns, and wherein at least some of the struts and/or crowns of the clot engaging section are aligned with the wave-like form to enhance embedding of clot.

### Claim 16 (depends on 13)

The method or use of claim 13, the proximal pinch section comprising one or more clot gripping features.

### Claim 17 (depends on 13)

The method or use of claim 13, the proximal pinch section is substantially curvilinear in the collapsed and expanded configurations.

### Claim 18 (depends on 13)

The method or use of claim 13, the proximal pinch section comprises a transverse cross section between peaks comprising both flat and curved sections.

### Claim 19 (depends on 13)

The method or use of claim 13, the proximal pinch section comprises a flat shape in transverse cross section.

### Claim 20

A method or use of restoring blood flow in neurovasculature by removing thrombus in a plurality of human patients experiencing ischemic stroke, the method or use comprising:
passing a first stent retriever device by, through, or about a cerebral occlusion in a blood vessel of one of the plurality of human patients; then
passing a revascularization device by, through, or about the cerebral occlusion in the blood vessel of the one of the plurality of human patients to restore perfusion to the blood vessel and achieve at least approximately 33% FPE (mTICI greater than or equal to 2c) after a first pass.
